Brief: Recro Pharma Awarded Development And Manufacturing Contract By National Institutes Of Health (Nih) To Support Novel Nasal Spray Analgesic
20/10/2021 12:21
Oct 20 (Reuters) - Recro Pharma Inc REPH.O :
* RECRO AWARDED DEVELOPMENT AND MANUFACTURING CONTRACT BY
NATIONAL
INSTITUTES OF HEALTH (NIH) TO SUPPORT NOVEL NASAL SPRAY
ANALGESIC
Source text for Eikon: ID:nGNX4zgGzV
Further company coverage: REPH.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview